I am a breastfeeding mother and i want to know if it is safe to use Capreomycine [INN-French]? Is Capreomycine [INN-French] safe for nursing mother and child? Does Capreomycine [INN-French] extracts into breast milk? Does Capreomycine [INN-French] has any long term or short term side effects on infants? Can Capreomycine [INN-French] influence milk supply or can Capreomycine [INN-French] decrease milk supply in lactating mothers?
- DrLact safety Score for Capreomycine [INN-French] is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Capreomycine [INN-French] may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Capreomycine [INN-French] may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Capreomycine [INN-French] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Capreomycine [INN-French] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Systemic absorption is minimal.
Developmental problems have been reported in two infants exposed to Capreomycine [INN-French] in breastmilk; however, their mothers were also exposed to several drugs during pregnancy and during breastfeeding, so the problems cannot necessarily be attributed to Capreomycine [INN-French]. Because Capreomycine [INN-French] is not orally absorbed it is unlikely to adversely affect the breastfed infant. If Capreomycine [INN-French] is required by the mother, it is not a reason to discontinue breastfeeding.
Capreomycine [INN-French] was used as part of multidrug regimens to treat two pregnant women with multidrug-resistant tuberculosis, one throughout pregnancy and postpartum and the other postpartum only. The infants were breastfed (extent and duration not stated). At age 4.6 and 5.1 years, the children were developing normally except for a mild speech delay in one and hyperactivity in the other.[1]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.